Analysts at StockNews.com began coverage on shares of Global Cord Blood (NYSE:CO – Get Free Report) in a report issued on Monday. The firm set a “strong-buy” rating on the medical research company’s stock.
Global Cord Blood Stock Performance
CO opened at $1.25 on Monday. The company’s 50 day simple moving average is $1.58 and its 200 day simple moving average is $1.38. Global Cord Blood has a 1 year low of $2.03 and a 1 year high of $5.50. The stock has a market capitalization of $151.94 million, a PE ratio of 1.95 and a beta of 0.16.
About Global Cord Blood
See Also
- Five stocks we like better than Global Cord Blood
- Bank Stocks – Best Bank Stocks to Invest In
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- What is the Hang Seng index?
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.